Haemonetics

(NYSE) HAE

Current Price$59.40

Market Cap$2.75B

Since IPO (1991)+898%

5 Year-12%

1 Year-6%

1 Month+5%

Haemonetics Financials at a Glance

Market Cap

$2.75B

Revenue (TTM)

$1.32B

Net Income (TTM)

$175.44M

EPS (TTM)

$3.64

P/E Ratio

16.28

Dividend

$0.00

Beta (Volatility)

0.73 (Low)

Dividend

$0.00

Beta (Volatility)

0.73 (Low)

Price

$59.40

Volume

20,557

Open

$59.88

Price

$59.40

Volume

20,557

Open

$59.88

Previous Close

$59.40

Daily Range

$59.24 - $60.56

52-Week Range

$47.31 - $87.32

Dividend

$0.00

Beta (Volatility)

0.73 (Low)

Price

$59.40

Volume

20,557

Open

$59.88

Previous Close

$59.40

Daily Range

$59.24 - $60.56

52-Week Range

$47.31 - $87.32

HAE News

What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year

Jonathan PoncianoMar 20, 2026

Page 1

HAE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Haemonetics

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

3,023

CEO

Christopher A. Simon, MBA

Website

www.haemonetics.com

Headquarters

Boston, MA 02110, US

HAE Financials

Key Financial Metrics (TTM)

Gross Margin

58%

Operating Margin

19%

Net Income Margin

13%

Return on Equity

19%

Return on Capital

13%

Return on Assets

Earnings Yield

6.14%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.75B

Shares Outstanding

46.47M

Volume

20.56K

Avg. Volume

808.85K

Financials (TTM)

Gross Profit

$778.55M

Operating Income

$221.82M

EBITDA

$355.99M

Operating Cash Flow

$181.72M

Capital Expenditure

$39.28M

Free Cash Flow

$142.45M

Cash & ST Invst.

$306.76M

Total Debt

$1.22B

Haemonetics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$338.97M

-2.7%

Gross Profit

$191.41M

-4.3%

Gross Margin

56.47%

N/A

Market Cap

$2.75B

N/A

Market Cap/Employee

$753.05K

N/A

Employees

3,657

N/A

Net Income

$44.74M

+19.3%

EBITDA

$95.48M

+0.4%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Net Cash

$861.37M

+4.7%

Accounts Receivable

$195.71M

-7.7%

Inventory

$321.19M

-10.7%

Long Term Debt

$919.99M

-24.6%

Short Term Debt

$304.75M

+5904.8%

Return on Assets

7.04%

N/A

Return on Invested Capital

12.98%

N/A

Free Cash Flow

$87.22M

+147.6%

Operating Cash Flow

$93.56M

+113.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

WRBYWarby Parker Inc.

WRBYWarby Parker Inc.$23.08+4.34%

ITGRInteger Holdings Corporation

ITGRInteger Holdings Corporation$84.03-5.06%

CONConcentra Group Holdings Parent, Inc.

CONConcentra Group Holdings Parent, Inc.$22.53+0.27%

LMATLeMaitre Vascular, Inc.

LMATLeMaitre Vascular, Inc.$112.04+2.09%

XRAYDENTSPLY SIRONA Inc.

XRAYDENTSPLY SIRONA Inc.$11.81+0.51%

BEAMBeam Therapeutics Inc.

BEAMBeam Therapeutics Inc.$30.70+1.22%

PINCPremier, Inc.

PINCPremier, Inc.$28.26+0.32%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

FFord Motor Company

FFord Motor Company$11.88-0.02%

Questions About HAE

What is the current price of Haemonetics?

Haemonetics is trading at $59.40 per share.

What is the 52-week range for Haemonetics?

Over the past 52 weeks, Haemonetics has traded between $47.32 and $87.32.

How much debt does Haemonetics have?

As of the most recent reporting period, Haemonetics reported total debt of $1.22B.

How much cash does Haemonetics have on hand?

Haemonetics reported $363.37M in cash and cash equivalents in its most recent financial results.

What is Haemonetics’s dividend yield?

Haemonetics does not currently have a dividend yield.

Haemonetics

Haemonetics Financials at a Glance

HAE News

What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year

SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million

Why Haemonetics Stock Was on Fire Thursday

Haemonetics (HAE) Q1 Revenue Falls 4%

Why Haemonetics Stock Dived by 15% Today

Why Haemonetics Stock Rallied on Friday

Why Haemonetics Stock Fell 13% Today

Why Baidu, Pandora Media, and Haemonetics Slumped Today

HAE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Haemonetics

HAE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Haemonetics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HAE

What is the current price of Haemonetics?

What is the 52-week range for Haemonetics?

How much debt does Haemonetics have?

How much cash does Haemonetics have on hand?

What is Haemonetics’s dividend yield?

Premium Investing Services